Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Pediatr Surg ; 58(12): 2429-2434, 2023 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-37652843

RESUMO

BACKGROUND: Postoperative bleeding and transfusion are correlated with mortality risk. Furthermore, postoperative bleeding may often initiate the cascade of complications that leads to death. Given that minority children have increased risk of surgical complications, this study aimed to investigate the association of race with pediatric surgical mortality following postoperative transfusion. METHODS: We used the NSQIP-P PUF to assemble a retrospective cohort of children <18 who underwent inpatient surgery during 2012-2021. We included White, Black, Hispanic, and 'Other' children who received a transfusion within 72 h of surgery. The primary outcome was defined as all-cause mortality within 30 days following the primary surgical procedure. Using logistic regression models, we estimated the risk-adjusted odds ratio (aOR) and 95% confidence intervals (CI) of mortality, comparing each racial/ethnic cohort to White children. RESULTS: A total of 466,230 children <18 years of age underwent inpatient surgical procedures from 2012 to 2021. Of these, 46,200 required transfusion and were included in our analysis. The majority of patients were non-Hispanic White (64.6%, n = 29,850), while 18.9% (n = 8752) were non-Hispanic Black, 11.7% (n = 5387) were Hispanic, and 4.8% (n = 2211) were 'Other' race. The overall rate of mortality following transfusion was 2.5%. White children had the lowest incidence of mortality (2.0%), compared to children of 'Other' race (2.5%), Hispanic children (3.1%), and Black children (3.6%). After adjusting for sex, age, comorbidities, case status, preoperative transfusion within 48 h, and year of operation, we found that Black children experienced 1.24 times the odds of mortality following a postoperative transfusion compared to a White child (aOR: 1.24; 95%CI, 1.03-1.51; P = 0.025). Hispanic children were also significantly more likely to die following a postoperative transfusion than White children (aOR: 1.19; 95%CI, 1.02-1.39; P = 0.027). CONCLUSION: We found that minority children who required a postoperative transfusion had a higher odds of death than White children. Future studies should explore adverse events following postoperative transfusion and the differences in their management by race that may contribute to the higher mortality rate for minority children. LEVEL OF EVIDENCE: Level II. CLINICAL TRIAL NUMBER AND REGISTRY: Not applicable.


Assuntos
Negro ou Afro-Americano , Transfusão de Sangue , Hemorragia Pós-Operatória , Criança , Humanos , Negro ou Afro-Americano/estatística & dados numéricos , Etnicidade , Hispânico ou Latino/estatística & dados numéricos , Estudos Retrospectivos , População Branca/estatística & dados numéricos , Procedimentos Cirúrgicos Operatórios/efeitos adversos , Procedimentos Cirúrgicos Operatórios/mortalidade , Procedimentos Cirúrgicos Operatórios/estatística & dados numéricos , Transfusão de Sangue/mortalidade , Transfusão de Sangue/estatística & dados numéricos , Recém-Nascido , Lactente , Pré-Escolar , Adolescente , Hemorragia Pós-Operatória/epidemiologia , Hemorragia Pós-Operatória/etnologia , Hemorragia Pós-Operatória/mortalidade , Hemorragia Pós-Operatória/terapia
2.
J Am Heart Assoc ; 8(22): e012874, 2019 11 19.
Artigo em Inglês | MEDLINE | ID: mdl-31701784

RESUMO

Background Data on racial disparities in major adverse cardiovascular events (MACE) and major hemorrhage (HEM) after percutaneous coronary intervention are limited. Factors contributing to these disparities are unknown. Methods and Results PRiME-GGAT (Pharmacogenomic Resource to Improve Medication Effectiveness-Genotype-Guided Antiplatelet Therapy) is a prospective cohort. Patients aged ≥18 years undergoing percutaneous coronary intervention were enrolled and followed for up to 1 year. Racial disparities in risk of MACE and HEM were assessed using an incident rate ratio. Sequential cumulative adjustment analyses were performed to identify factors contributing to these disparities. Data from 919 patients were included in the analysis. Compared with white patients, black patients (n=203; 22.1% of the cohort) were younger and were more likely to be female, to be a smoker, and to have higher body mass index, lower socioeconomic status, higher prevalence of diabetes mellitus and moderate to severe chronic kidney disease, and presentation with acute coronary syndrome and to undergo urgent percutaneous coronary intervention. The incident rates of MACE (34.1% versus 18.2% per 100 person-years, P<0.001) and HEM (17.7% versus 10.3% per 100 person-years, P=0.02) were higher in black patients. The incident rate ratio was 1.9 (95% CI, 1.3-2.6; P<0.001) for MACE and 1.7 (95% CI, 1.1-2. 7; P=0.02) for HEM. After adjustment for nonclinical and clinical factors, black race was not significantly associated with outcomes. Rather, differences in socioeconomic status, comorbidities, and coronary heart disease severity were attributed to racial disparities in outcomes. Conclusions Despite receiving similar treatment, racial disparities in MACE and HEM still exist. Opportunities exist to narrow these disparities by mitigating the identified contributors.


Assuntos
Negro ou Afro-Americano/estatística & dados numéricos , Estenose Coronária/cirurgia , AVC Isquêmico/etnologia , Infarto do Miocárdio/etnologia , Intervenção Coronária Percutânea , Hemorragia Pós-Operatória/etnologia , Classe Social , População Branca/estatística & dados numéricos , Síndrome Coronariana Aguda/epidemiologia , Síndrome Coronariana Aguda/cirurgia , Distribuição por Idade , Idoso , Índice de Massa Corporal , Causas de Morte , Comorbidade , Estenose Coronária/epidemiologia , Diabetes Mellitus/epidemiologia , Escolaridade , Feminino , Disparidades nos Níveis de Saúde , Humanos , Incidência , Renda/estatística & dados numéricos , Seguro Saúde/estatística & dados numéricos , Ataque Isquêmico Transitório/epidemiologia , Ataque Isquêmico Transitório/etnologia , AVC Isquêmico/epidemiologia , Masculino , Medicaid , Pessoas sem Cobertura de Seguro de Saúde , Medicare , Pessoa de Meia-Idade , Mortalidade , Infarto do Miocárdio/epidemiologia , Obesidade/epidemiologia , Complicações Pós-Operatórias/epidemiologia , Complicações Pós-Operatórias/etnologia , Hemorragia Pós-Operatória/epidemiologia , Estudos Prospectivos , Insuficiência Renal Crônica/epidemiologia , Índice de Gravidade de Doença , Distribuição por Sexo , Fumar/epidemiologia , Stents , Trombose/epidemiologia , Trombose/etnologia , Estados Unidos/epidemiologia
3.
Gen Thorac Cardiovasc Surg ; 63(5): 260-6, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25416165

RESUMO

OBJECTIVES: The aim of this study was to explore the influence of the characteristics of Japanese patients on the long-term outcomes after aortic valve replacement with either mechanical or biological prostheses by means of a microsimulation. METHODS: A microsimulation model was used to simulate the lives of patients living in Japan and in the United States after aortic valve replacement. The background mortality data taken from the 21st complete life table of Japan and the bleeding hazard determined from a meta-analysis of long-term results in Japanese institutions were used to simulate Japanese patients. The life expectancy, event-free life expectancy, and lifetime risk of structural valve degeneration were calculated. A sensitivity analysis for various bleeding hazards was performed. RESULTS: Regarding the event-free life expectancy, the age crossover points between the two valve types were 64-65 and 57-58 years for Japanese and American patients, respectively. Regarding the life expectancy, the age crossover points were 88-89 and 64-65 years, respectively, for Japanese and American patients. The lifetime risk of structural valve degeneration was higher in Japanese patients than in American patients. The sensitivity analysis showed that the age crossover points were sensitive to the hazard of bleeding complications. CONCLUSIONS: The long-term clinical outcomes after aortic valve replacement were simulated with a microsimulation model. The results indicated that the age crossover points in the advantages and disadvantages between mechanical valves and bioprostheses may be higher in Japanese patients than in American subjects.


Assuntos
Bioprótese/efeitos adversos , Doenças das Valvas Cardíacas/cirurgia , Implante de Prótese de Valva Cardíaca/mortalidade , Próteses Valvulares Cardíacas/efeitos adversos , Idoso , Idoso de 80 Anos ou mais , Valva Aórtica/cirurgia , Simulação por Computador , Feminino , Doenças das Valvas Cardíacas/etnologia , Implante de Prótese de Valva Cardíaca/efeitos adversos , Humanos , Japão/etnologia , Expectativa de Vida/etnologia , Masculino , Pessoa de Meia-Idade , Método de Monte Carlo , Hemorragia Pós-Operatória/etnologia , Hemorragia Pós-Operatória/etiologia , Hemorragia Pós-Operatória/mortalidade , Reoperação/mortalidade , Resultado do Tratamento , Estados Unidos/etnologia
4.
J Vasc Surg ; 57(5): 1325-30, 2013 May.
Artigo em Inglês | MEDLINE | ID: mdl-23375438

RESUMO

OBJECTIVE: Racial disparities in the outcomes of patients undergoing carotid endarterectomy (CEA) have been reported. We sought to examine the contemporary relationship between race and outcomes and to report postdischarge events after CEA. METHODS: The American College of Surgeons National Surgical Quality Improvement Program Participant Use Data Files were reviewed to identify all CEAs performed from 2005 to 2010 by vascular surgeons. The influence of race on outcomes was examined. Multivariate analysis was performed using variables found to be significant on bivariate analysis. The primary outcomes were stroke and mortality. Secondary outcomes were other 30-day complications, including postdischarge events. RESULTS: CEA was performed on 29,114 white patients (95.7%) and on 1316 black patients (4.3%); the overall stroke and mortality rates were 1.65% and 0.7%, respectively. The stroke rate was 1.6% for whites and 2.5% blacks (P = .009). The 30-day mortality rate was 0.7% for whites and 1.4% for blacks (P = .002). There was a longer operating time (P < .001) and total length of stay (P < .001), more postoperative pneumonias (P = .049), unplanned intubations (P < .001), ventilator dependence (P < .001), cardiac arrests (P < .001), bleeding requiring transfusions (P = .024), and reoperations within 30 days (P = .021) among black patients. Multivariate logistic regression modeling identified black race as an independent risk factor for 30-day mortality (odds ratio, 1.9; P = .007). Black patients also had a greater proportion of in-hospital deaths than white patients (73.7% vs 43.1%; P = .01). There was no between-group difference in the rate of postdischarge strokes. Thirty-six percent of all strokes occurred after discharge at a mean of 8.3 days, and 54.3% of deaths occurred after discharge at a mean of 11 days. CONCLUSIONS: Black race is an independent risk factor for 30-day mortality after CEA. A significant proportion of strokes and deaths occur after discharge in both racial groups evaluated.


Assuntos
Negro ou Afro-Americano , Doenças das Artérias Carótidas/cirurgia , Endarterectomia das Carótidas/efeitos adversos , Endarterectomia das Carótidas/mortalidade , Disparidades nos Níveis de Saúde , Acidente Vascular Cerebral/etnologia , Acidente Vascular Cerebral/mortalidade , População Branca , Idoso , Idoso de 80 Anos ou mais , Transfusão de Sangue , Doenças das Artérias Carótidas/etnologia , Doenças das Artérias Carótidas/mortalidade , Distribuição de Qui-Quadrado , Feminino , Parada Cardíaca/etnologia , Parada Cardíaca/mortalidade , Humanos , Intubação Intratraqueal , Tempo de Internação , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Razão de Chances , Alta do Paciente , Pneumonia/etnologia , Pneumonia/mortalidade , Hemorragia Pós-Operatória/etnologia , Hemorragia Pós-Operatória/mortalidade , Hemorragia Pós-Operatória/terapia , Respiração Artificial , Medição de Risco , Fatores de Risco , Fatores de Tempo , Resultado do Tratamento , Estados Unidos/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA